Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study

NCT00497770 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00497770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00497770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-small Cell Lung Cancer: The Impact of Ethnic Origin on Patients Being Treated Second Line With Pemetrexed - An Observational Study
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
February 28, 2007
Completion date
March 31, 2011
Enrollment
434 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms